Geopolitical worries have added another layer of volatility to an already-jumpy market as investors price in the possibility of escalating conflict between Russia and Ukraine

White House warnings of a possibly imminent Russian invasion of Ukraine reverberated through financial markets with stocks tumbling on Wall Street on Friday and oil prices surging.

The recommendation, which sent Innovent shares down, raises concerns for other Chinese drugmakers seeking to bring products to the US market

The EU member enraged China last year when it allowed Taipei to open a representative office in Vilnius under the name of Taiwan

Canada said it opposed 'economic coercion' and would stand with 'like-minded partners in supporting rules-based international trade' at the WTO.

The carmaker faces scrutiny from regulators who have accused it of pushing safety limits and discrimination against African-Americans and women

China remained at the top of the rankings with 69,540 filings, a mere 0.9% increase over 2020 following a 16% jump that year over 2019

“We’re making significant investments ... that will pay off in the long term,” she said, referring to the metaverse, and signalling a short-term slowdown

Analysis found that 38% of the credits - equivalent to 73 million tonnes of CO2 - were over five years old, while more than 4% were at least 10 years old

Xpeng first entered Europe when it launched in Norway in 2020 and the company said it will open a store in Stockholm this week

The Financial Stability Board, which groups regulators, central banks and finance officials from G20 economies, is looking at what needs to be done with cryptoassets such as bitcoin and stablecoins

Sintilimab, made by Suzhou-based Innovent and US drugmaker Eli Lilly, has been developed and commercialised under a global agreement